HYBE Co., Ltd. (KRX:352820)

CTI BioPharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	10,454,676	8,055,516	9,725,765	7,174,813	14,432,332	5,699,802
Market Cap Growth	2.39%	-17.17%	35.55%	-50.29%	153.21%	-
Enterprise Value	10,631,001	8,359,494	9,663,829	6,862,799	14,362,984	5,849,832
Last Close Price	251000.00	193233.63	233299.14	172815.01	347622.13	157490.95
PE Ratio	199.67	858.82	51.94	137.13	105.50	66.49
Forward PE	35.62	32.47	32.10	29.54	52.71	35.59
PS Ratio	4.36	3.57	4.47	4.04	11.49	7.16
PB Ratio	2.93	2.29	3.13	2.45	5.00	4.75
P/TBV Ratio	9.86	8.30	12.90	5.52	9.74	6.29
P/FCF Ratio	54.43	67.95	33.78	21.74	117.12	73.84
P/OCF Ratio	46.19	53.14	31.31	20.67	81.42	48.85
PEG Ratio	1.23	1.74	0.34	1.00	0.68	0.77
EV/Sales Ratio	4.44	3.71	4.44	3.86	11.44	7.35
EV/EBITDA Ratio	35.03	25.32	22.86	19.28	52.62	32.39
EV/EBIT Ratio	68.29	45.42	32.71	28.94	75.74	40.17
EV/FCF Ratio	55.35	70.51	33.57	20.79	116.55	75.78
Debt / Equity Ratio	0.30	0.31	0.36	0.38	0.43	0.29
Debt / EBITDA Ratio	3.20	3.30	2.62	3.13	4.49	1.90
Debt / FCF Ratio	5.65	9.20	3.84	3.38	9.95	4.45
Asset Turnover	0.44	0.42	0.43	0.37	0.38	0.70
Inventory Turnover	8.86	8.97	11.40	11.50	8.72	11.25
Quick Ratio	1.81	1.83	0.94	2.29	3.13	4.32
Current Ratio	2.18	2.15	1.07	2.49	3.42	4.69
Return on Equity (ROE)	1.19%	-0.10%	6.08%	1.65%	6.89%	12.64%
Return on Assets (ROA)	2.21%	2.13%	3.62%	3.09%	3.56%	7.96%
Return on Capital (ROIC)	2.68%	2.61%	4.47%	3.64%	4.19%	10.52%
Return on Capital Employed (ROCE)	4.10%	4.00%	8.30%	5.90%	4.60%	8.90%
Earnings Yield	0.50%	0.12%	1.93%	0.73%	0.95%	1.50%
FCF Yield	1.84%	1.47%	2.96%	4.60%	0.85%	1.35%
Dividend Yield	0.08%	0.10%	-	-	-	-
Payout Ratio	55.73%	310.84%	-	-	-	-
Buyback Yield / Dilution	0.11%	-0.09%	-0.55%	-9.10%	-24.52%	-5.65%
Total Shareholder Return	0.19%	0.01%	-0.55%	-9.10%	-24.52%	-5.65%

Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.